Eyenuk, Inc. is a global artificial intelligence (AI) digital health company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer's disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/17/22 | $26,000,000 | Series A |
A&C Foelsgaard Alternativer ApS AXA IM Alts Kendall Capital Partners T&W Medical | undisclosed |
